Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
    24.
    发明授权
    Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery 失效
    靶向M细胞的聚合脂质体可用于口服或粘膜药物递送

    公开(公告)号:US06387397B1

    公开(公告)日:2002-05-14

    申请号:US09324458

    申请日:1999-06-02

    IPC分类号: A61K9127

    摘要: The present invention relates to targeted polymerized liposomes for oral and/or mucosal delivery of vaccines, allergens and therapeutics. In particular, the present invention relates to polymerized liposomes which have been modified on their surface to contain a molecule or ligand which targets the polymerized liposome to a specific site or cell type. More particularly, the invention relates to the use of polymerized liposomes modified to contain a carbohydrate or lectin on their surface.

    摘要翻译: 本发明涉及用于口服和/或粘膜递送疫苗,变应原和治疗剂的目标聚合脂质体。 特别地,本发明涉及在其表面上被修饰以包含将聚合脂质体靶向特定部位或细胞类型的分子或配体的聚合脂质体。 更具体地说,本发明涉及经修饰的聚合脂质体在其表面上含有碳水化合物或凝集素的用途。

    System and method for optimizing tissue barrier transfer of compounds
    26.
    发明授权
    System and method for optimizing tissue barrier transfer of compounds 失效
    用于优化化合物组织阻挡转移的系统和方法

    公开(公告)号:US07172859B2

    公开(公告)日:2007-02-06

    申请号:US10371372

    申请日:2003-02-20

    IPC分类号: C12Q1/00

    CPC分类号: G01N33/5088 G01N13/00

    摘要: The present invention relates to high-throughput systems and methods to prepare a large number of component combinations, at varying concentrations and identities, at the same time, and high-throughput methods to test tissue barrier transfer, such as transdermal transfer, of components in each combination. The methods of the present invention allow determination of the effects of inactive components, such as solvents, excipients, enhancers, adhesives and additives, on tissue barrier transfer of active components, such as pharmaceuticals. The invention thus encompasses the high-throughput testing of pharmaceutical compositions or formulations in order to determine the overall optimal composition or formulation for improved tissue transport, such as transdermal transport.

    摘要翻译: 本发明涉及高通量系统和方法,以同时以不同的浓度和同一性制备大量组分组合,以及高通量方法来测试组织屏障转移,例如透皮转移 每个组合。 本发明的方法允许测定非活性组分如溶剂,赋形剂,增强剂,粘合剂和添加剂对活性组分如药物的组织屏障转移的影响。 因此,本发明包括药物组合物或制剂的高通量测试,以便确定用于改善组织转运的总体最佳组合物或制剂,例如透皮转运。

    System and method for optimizing tissue barrier transfer of compounds
    28.
    发明授权
    System and method for optimizing tissue barrier transfer of compounds 失效
    用于优化化合物组织阻挡转移的系统和方法

    公开(公告)号:US06758099B2

    公开(公告)日:2004-07-06

    申请号:US09904725

    申请日:2001-07-13

    IPC分类号: G01F100

    摘要: The present invention relates to high-throughput systems and methods to prepare a large number of component combinations, at varying concentrations and identities, at the same time, and high-throughput methods to test tissue barrier transfer, such as transdermal transfer, of components in each combination. The methods of the present invention allow determination of the effects of inactive components, such as solvents, excipients, enhancers, adhesives and additives, on tissue barrier transfer of active components, such as pharmaceuticals. The invention thus encompasses the high-throughput testing of pharmaceutical compositions or formulations in order to determine the overall optimal composition or formulation for improved tissue transport, such as transdermal transport.

    摘要翻译: 本发明涉及高通量系统和方法,以同时以不同的浓度和同一性制备大量组分组合,以及高通量方法来测试组织屏障转移,例如透皮转移 每个组合。 本发明的方法允许测定非活性组分如溶剂,赋形剂,增强剂,粘合剂和添加剂对活性组分如药物的组织屏障转移的影响。 因此,本发明包括药物组合物或制剂的高通量测试,以便确定用于改善组织转运的总体最佳组合物或制剂,例如透皮转运。